13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

      Nature reviews. Drug discovery

      Animals, Antineoplastic Agents, chemistry, therapeutic use, Antiviral Agents, Drug Discovery, methods, trends, Humans, Neoplasms, drug therapy, metabolism, Nucleosides, Nucleotides, Signal Transduction, drug effects, physiology, Virus Replication

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nucleoside analogues have been in clinical use for almost 50 years and have become cornerstones of treatment for patients with cancer or viral infections. The approval of several additional drugs over the past decade demonstrates that this family still possesses strong potential. Here, we review new nucleoside analogues and associated compounds that are currently in preclinical or clinical development for the treatment of cancer and viral infections, and that aim to provide increased response rates and reduced side effects. We also highlight the different approaches used in the development of these drugs and the potential of personalized therapy.

          Related collections

          Author and article information

          Journal
          23722347
          10.1038/nrd4010

          Comments

          Comment on this article